You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 6, June 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Studies
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Inhibition of a Model of In Vitro Granuloma Formation by Tetracyclines and Ciprofloxacin

Involvement of Protein Kinase C

Guy F. Webster, MD; Susan M. Toso, MS; Lutz Hegemann, MD

Arch Dermatol. 1994;130(6):748-752.


Abstract

Background and Design
Granulomatous inflammation is a common component of many diseases. In this study the ability of commonly used antibiotics to inhibit an in vitro model of granuloma formation were studied. The effect of protein kinase C inhibition in this system was also investigated.

Results
Ampicillin, cephalothin, metronidazole, rifampin, isoniazide, erythromycin, and clindamycin were inactive in inhibiting granuloma formation. Tetracycline, doxycycline, minocycline, and ciprofloxacin produced dose-dependent inhibition of the granuloma model in concentrations between 10-4 and 10-6 mol/L. The approximate order of decending potency was doxycycline equals minocycline greater than tetracycline greater than ciprofloxacin. The same drugs were tested for the ability to inhibit protein kinase C. Drugs inactive in the granuloma model had no effect on protein kinase C activity. The tetracyclines and ciprofloxacin all caused a dose-dependent inhibition of protein kinase C activity in the same order of relative potency as was found for inhibition of granuloma formation.

Conclusions
These data demonstrate a previously unappreciated activity of the tetracyclines and ciprofloxacin. Inhibition of granuloma formation helps to account for the activity of these drugs in the severest forms of inflammatory acne.

(Arch Dermatol. 1994;130:748-752)



Author Affiliations

From the Department of Dermatology, Jefferson Medical College, Philadelphia, Pa.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Minocycline for the Treatment of Ocular and Ocular Adnexal Sarcoidosis
Park et al.
Arch Ophthalmol 2007;125:705-709.
FULL TEXT  

Papular Facial Eruption in an African American Adolescent--Diagnosis
Arch Dermatol 2006;142:775-780.
FULL TEXT  

Doxycycline Is Anti-Inflammatory and Inhibits Staphylococcal Exotoxin-Induced Cytokines and Chemokines
Krakauer and Buckley
Antimicrob. Agents Chemother. 2003;47:3630-3633.
ABSTRACT | FULL TEXT  

Mesenchymal Chondrosarcoma: Molecular Characterization by a Proteomic Approach, with Morphogenic and Therapeutic Implications
Brown and Boyle
Annals of Clinical & Laboratory Science 2003;33:131-141.
ABSTRACT | FULL TEXT  

The Use of Tetracyclines for the Treatment of Sarcoidosis
Bachelez et al.
Arch Dermatol 2001;137:69-73.
ABSTRACT | FULL TEXT  

Antibiotics Modulate Vaccine-Induced Humoral Immune Response
Woo et al.
CVI 1999;6:832-837.
ABSTRACT | FULL TEXT  

Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms
Golub et al.
ADR 1998;12:12-26.
ABSTRACT  

Modulation of Nitric Oxide Production by Tetracyclines and Chemically Modified Tetracyclines
Cillari et al.
ADR 1998;12:126-130.
ABSTRACT  

Dermatology and the Evolution of Therapies to Control Inflammatory Tissue Injury
Lorincz
Arch Dermatol 1994;130:781-782.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.